Department of Medicine and Surgery, Unit of Radiologic Science, University of Parma, Maggiore Hospital, Via Gramsci 14, Parma, Italy.
Department of Medicine and Surgery, Unit of Interventional Radiology, University of Parma, Maggiore Hospital, Via Gramsci 14, Parma, Italy.
Radiol Med. 2021 Mar;126(3):494-497. doi: 10.1007/s11547-020-01294-9. Epub 2020 Oct 12.
Percutaneous renal artery embolization is a valid non-invasive technique alternative to nephrectomy for patients with symptomatic non-functioning allograft (graft intolerance syndrome-GIS). The purpose of this article is to report the experience of our centre.
We analysed retrospectively 15 patients with symptomatic non-functioning renal allograft treated with percutaneous embolization from 2003 to 2017. Occlusion was obtained with the injection of calibrated microspheres of increasing size (from 100 to 900 μm) and completed with 5 to 8 mm metal coils placement in the renal artery.
Technical success was achieved in all cases at the end of the procedure. Clinical success was obtained in 11 patients (73%). In four cases, nephrectomy was necessary: in one case because of septic fever and in three cases because of GIS persistence. In one case, it was possible to perform another procedure to embolize a perirenal collateral from a lumbar artery. Four patients (27%) reported minor complications which spontaneously resolved during the hospital stay.
According to the scientific literature, we believe that, in selected patients, percutaneous renal artery embolization is a valid treatment option for GIS thanks to its efficacy, repeatability, minimal invasiveness and the absence of severe complications.
经皮肾动脉栓塞术是一种有效的非侵入性技术,可替代肾切除术治疗有症状的无功能移植物(移植物不耐受综合征-GIS)患者。本文旨在报告我们中心的经验。
我们回顾性分析了 2003 年至 2017 年间 15 例接受经皮栓塞治疗的有症状无功能肾移植患者。通过注射不同大小(100-900μm)的校准微球来实现闭塞,并在肾动脉中放置 5-8mm 的金属线圈完成闭塞。
在手术结束时,所有病例均达到技术成功。11 例患者(73%)获得临床成功。在 4 例中,需要进行肾切除术:1 例因败血症发热,3 例因 GIS 持续存在。在 1 例中,能够进行另一次手术,用来自腰动脉的肾周侧支栓塞。4 例(27%)患者报告有轻微并发症,在住院期间自行缓解。
根据科学文献,我们认为,在选择的患者中,经皮肾动脉栓塞术是治疗 GIS 的有效治疗选择,其疗效、可重复性、微创性和无严重并发症。